UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
![]() |
|||||||
|
Fusion Protein:CYP2S1-UPF1 |
Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: CYP2S1-UPF1 | FusionPDB ID: 21065 | FusionGDB2.0 ID: 21065 | Hgene | Tgene | Gene symbol | CYP2S1 | UPF1 | Gene ID | 29785 | 5976 |
Gene name | cytochrome P450 family 2 subfamily S member 1 | UPF1 RNA helicase and ATPase | |
Synonyms | CYPIIS1 | HUPF1|NORF1|RENT1|pNORF1|smg-2 | |
Cytomap | 19q13.2 | 19p13.11 | |
Type of gene | protein-coding | protein-coding | |
Description | cytochrome P450 2S1cytochrome P450, family 2, subfamily S, polypeptide 1cytochrome P540, subfamily IIS, polypeptide 1hydroperoxy icosatetraenoate dehydratasethromboxane-A synthase | regulator of nonsense transcripts 1ATP-dependent helicase RENT1UPF1 regulator of nonsense transcripts homologdelta helicasenonsense mRNA reducing factor 1smg-2 homolog, nonsense mediated mRNA decay factorup-frameshift mutation 1 homologup-frameshif | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | Q96SQ9 | . | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000310054, ENST00000542619, | ENST00000600310, ENST00000262803, ENST00000599848, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 1 X 1 X 1=1 | 8 X 7 X 5=280 |
# samples | 1 | 9 | |
** MAII score | log2(1/1*10)=3.32192809488736 | log2(9/280*10)=-1.63742992061529 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: CYP2S1 [Title/Abstract] AND UPF1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | CYP2S1(41703833)-UPF1(18976098), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | CYP2S1-UPF1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. CYP2S1-UPF1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. CYP2S1-UPF1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. CYP2S1-UPF1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | CYP2S1 | GO:0006690 | icosanoid metabolic process | 21068195 |
Hgene | CYP2S1 | GO:0006693 | prostaglandin metabolic process | 21068195 |
Hgene | CYP2S1 | GO:0042573 | retinoic acid metabolic process | 12711469 |
Tgene | UPF1 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 17468741 |
Tgene | UPF1 | GO:0006281 | DNA repair | 16488880 |
Tgene | UPF1 | GO:0032201 | telomere maintenance via semi-conservative replication | 21829167 |
Tgene | UPF1 | GO:0061014 | positive regulation of mRNA catabolic process | 24726324 |
Tgene | UPF1 | GO:0061158 | 3'-UTR-mediated mRNA destabilization | 24726324 |
Tgene | UPF1 | GO:0071222 | cellular response to lipopolysaccharide | 26255671 |
Tgene | UPF1 | GO:0071347 | cellular response to interleukin-1 | 26255671 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Fusion Gene Sample Information |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | LUSC | TCGA-34-5240-01A | CYP2S1 | chr19 | 41703833 | + | UPF1 | chr19 | 18976098 | + |
Top |
Fusion ORF Analysis |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000310054 | CYP2S1 | chr19 | 41703833 | + | ENST00000262803 | UPF1 | chr19 | 18976098 | + | 2928 | 709 | 105 | 1208 | 367 |
ENST00000310054 | CYP2S1 | chr19 | 41703833 | + | ENST00000599848 | UPF1 | chr19 | 18976098 | + | 2921 | 709 | 105 | 1208 | 367 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000310054 | ENST00000262803 | CYP2S1 | chr19 | 41703833 | + | UPF1 | chr19 | 18976098 | + | 0.009518466 | 0.99048156 |
ENST00000310054 | ENST00000599848 | CYP2S1 | chr19 | 41703833 | + | UPF1 | chr19 | 18976098 | + | 0.009434285 | 0.9905657 |
Top |
Fusion Amino Acid Sequences |
![]() |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >21065_21065_1_CYP2S1-UPF1_CYP2S1_chr19_41703833_ENST00000310054_UPF1_chr19_18976098_ENST00000262803_length(amino acids)=367AA_BP=43 MPRPAPDFVGEGDARLPPLTSPAARSAWERRRSRPAEMEATGTWALLLALALLLLLTLALSGTRARGHLPPGPTPLPLLGNLLQLRPGAL YSGLMRLSKKYGPVFTIYLGPWRPVVVLVGQEAVREALGGQAEEFSGRGTVAMLEGTFDGHGVFFSNGERWRQLRKFTMLALRDLGMGKR EGEELIQAEARCLVETFQGTEGRPSSMYFQTHDQIGMISAGPSHVAAMNIPIPFNLVMPPMPPPGYFGQANGPAAGRGTPKGKTGRGGRQ KNRFGLPGPSQTNLPNSQASQDVASQPFSQGALTQGYISMSQPSQMSQPGLSQPELSQDSYLGDEFKSQIDVALSQDSTYQGERAYQHGG -------------------------------------------------------------- >21065_21065_2_CYP2S1-UPF1_CYP2S1_chr19_41703833_ENST00000310054_UPF1_chr19_18976098_ENST00000599848_length(amino acids)=367AA_BP=43 MPRPAPDFVGEGDARLPPLTSPAARSAWERRRSRPAEMEATGTWALLLALALLLLLTLALSGTRARGHLPPGPTPLPLLGNLLQLRPGAL YSGLMRLSKKYGPVFTIYLGPWRPVVVLVGQEAVREALGGQAEEFSGRGTVAMLEGTFDGHGVFFSNGERWRQLRKFTMLALRDLGMGKR EGEELIQAEARCLVETFQGTEGRPSSMYFQTHDQIGMISAGPSHVAAMNIPIPFNLVMPPMPPPGYFGQANGPAAGRGTPKGKTGRGGRQ KNRFGLPGPSQTNLPNSQASQDVASQPFSQGALTQGYISMSQPSQMSQPGLSQPELSQDSYLGDEFKSQIDVALSQDSTYQGERAYQHGG -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr19:41703833/chr19:18976098) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
CYP2S1 | . |
FUNCTION: A cytochrome P450 monooxygenase involved in the metabolism of retinoids and eicosanoids (PubMed:12711469, PubMed:21068195). In epidermis, may contribute to the oxidative metabolism of all-trans-retinoic acid. For this activity, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase) (PubMed:12711469). Additionally, displays peroxidase and isomerase activities toward various oxygenated eicosanoids such as prostaglandin H2 (PGH2) and hydroperoxyeicosatetraenoates (HPETEs) (PubMed:21068195). Independently of cytochrome P450 reductase, NADPH, and O2, catalyzes the breakdown of PGH2 to hydroxyheptadecatrienoic acid (HHT) and malondialdehyde (MDA), which is known to act as a mediator of DNA damage (PubMed:21068195). {ECO:0000269|PubMed:12711469, ECO:0000269|PubMed:21068195}. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
![]() |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | UPF1 | chr19:41703833 | chr19:18976098 | ENST00000262803 | 19 | 24 | 1042_1129 | 952.3333333333334 | 1523.3333333333333 | Compositional bias | Note=Gln/Ser-rich | |
Tgene | UPF1 | chr19:41703833 | chr19:18976098 | ENST00000599848 | 19 | 24 | 1042_1129 | 963.3333333333334 | 1553.0 | Compositional bias | Note=Gln/Ser-rich | |
Tgene | UPF1 | chr19:41703833 | chr19:18976098 | ENST00000262803 | 19 | 24 | 1089_1090 | 952.3333333333334 | 1523.3333333333333 | Motif | Note=[ST]-Q motif 1 | |
Tgene | UPF1 | chr19:41703833 | chr19:18976098 | ENST00000262803 | 19 | 24 | 1107_1108 | 952.3333333333334 | 1523.3333333333333 | Motif | Note=[ST]-Q motif 2 | |
Tgene | UPF1 | chr19:41703833 | chr19:18976098 | ENST00000599848 | 19 | 24 | 1089_1090 | 963.3333333333334 | 1553.0 | Motif | Note=[ST]-Q motif 1 | |
Tgene | UPF1 | chr19:41703833 | chr19:18976098 | ENST00000599848 | 19 | 24 | 1107_1108 | 963.3333333333334 | 1553.0 | Motif | Note=[ST]-Q motif 2 |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | UPF1 | chr19:41703833 | chr19:18976098 | ENST00000262803 | 19 | 24 | 47_80 | 952.3333333333334 | 1523.3333333333333 | Compositional bias | Note=Ala/Gly/Pro-rich | |
Tgene | UPF1 | chr19:41703833 | chr19:18976098 | ENST00000599848 | 19 | 24 | 47_80 | 963.3333333333334 | 1553.0 | Compositional bias | Note=Ala/Gly/Pro-rich | |
Tgene | UPF1 | chr19:41703833 | chr19:18976098 | ENST00000262803 | 19 | 24 | 506_510 | 952.3333333333334 | 1523.3333333333333 | Nucleotide binding | Note=ATP | |
Tgene | UPF1 | chr19:41703833 | chr19:18976098 | ENST00000599848 | 19 | 24 | 506_510 | 963.3333333333334 | 1553.0 | Nucleotide binding | Note=ATP | |
Tgene | UPF1 | chr19:41703833 | chr19:18976098 | ENST00000262803 | 19 | 24 | 121_272 | 952.3333333333334 | 1523.3333333333333 | Zinc finger | Note=UPF1-type | |
Tgene | UPF1 | chr19:41703833 | chr19:18976098 | ENST00000599848 | 19 | 24 | 121_272 | 963.3333333333334 | 1553.0 | Zinc finger | Note=UPF1-type |
Top |
Fusion Protein-Protein Interaction |
![]() |
![]() |
Gene | PPI interactors |
![]() |
Gene | STRING network |
CYP2S1 | |
UPF1 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to CYP2S1-UPF1 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to CYP2S1-UPF1 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |